AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

AngioDynamics, Inc.

Activ Surgical is involved in the development of surgical technologies and tools. Self-described as innovative, it focuses on enhancing surgical procedures through its technological offerings.

Activ Surgical

Integrated Surgical is a Service-Disabled Veteran Owned Small Business that specializes in federal healthcare supply chain and contracting expertise, combining clinical sales and marketing.

Integrated Surgical

AngioDynamics develops, manufactures, and markets medical devices for the treatment of cardiovascular disease and cancer.

Metric
Company Name	AngioDynamics, Inc.	Activ Surgical	Integrated Surgical
Symbol	ANGO
MSH ID	COM:ANGIODYNAMICS	COM:ACTIVSURGICAL	COM:INTEGRATEDSURG
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices	Medical Equipment and Supplies
Country	US	US	US
Stage
Employee Count	815
Website	angiodynamics.com	activsurgical.com	integratedsurg.com
LinkedIn
Founders

Metric
Market Cap	224.31M
Enterprise Value
Monthly Web Traffic		973
Web Traffic Growth		12.51
Valuation
Raised Capital

Metric
Revenue	303.91M
Revenue (LTM)
Revenue (NTM)
Gross Profit	141.65M
EBITDA	-6.10M
Operating Income	-33.84M
Net Income	-184.35M
EPS	-4.59
Diluted EPS	-4.59
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.51
Operating Profit Margin	0.04
EBITDA Margin	-0.02
Net Profit Margin	-0.04
Return on Equity	-0.04
Return on Assets	-0.03
Return on Capital Employed	0.03

COM:ANGIODYNAMICS

AngioDynamics

Last Close

6.95

22/11 21:00

Market Cap

224.31M

Beta: -

Volume Today

387.31K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-16.80
P/B Ratio	0.59
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.07
EV Multiple	53.92

Metric
Days Sales Outstanding	57.16
Days Payables Outstanding	84.64
Days Inventory Outstanding	160.40
Operating Cycle	209.74
Cash Conversion Cycle	132.21
Asset Turnover	1.00

Metric
Operating Cash Flow	-28.16M
Free Cash Flow	-38.94M
Cash Flow to Debt
Operating Cash Flow/Sales	-0.01
Free Cash Flow Yield	-0.03

Metric
Cash & Equivalents	76.06M
Accounts Receivable	7.89M
Inventory	60.62M
Goodwill
Debt to Capitalization	0.03
Debt to Assets
Current Ratio	2.38
Quick Ratio	1.49

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03
R&D to Revenue	0.10
SG&A to Revenue	0.12